Hiv Tat Injection
Hiv Tat Injection - Related Videos
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
0 Views •
Cited by 15 •
2014
Here we describe cellular cytotoxicity and single round infectivity assays that allow for the rapid and accurate screening of compounds to determine their cellular cytotoxicity (CC50) and IC50 values against WT and drug resistant HIV-1.
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
0 Views •
Cited by 10 •
2011
Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral loads.
10:04
Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
0 Views •
Cited by 4 •
2016
This paper describes a method by which the vascular architecture in the brain can be quantified using in vivo and ex vivo two-photon microscopy.
13:08
Visualizing Cell-to-cell Transfer of HIV using Fluorescent Clones of HIV and Live Confocal Microscopy
0 Views •
Cited by 4 •
2010
This visualized experiment is a guide for utilizing a fluorescent molecular clone of HIV for live confocal imaging experiments.
03:13
Establishing an Active HIV Infection in a Rat Model
0 Views •
2025
This video demonstrates the procedure of injecting chimeric HIV viruses into the cortex of a rat's brain, where the virus RNA integrates into the host genome, replicates, and spreads to establish an active HIV infection in the experimental model.
FAQs
Tat can enter cells and alter gene regulation and intracellular signaling. These changes may affect how neural cells respond to stress and communicate with surrounding cells, creating experimental links between viral protein exposure and neuronal dysfunction. Studying these intracellular effects helps researchers identify molecular events that may contribute to HIV-associated neurological disorders.
Oxidative stress and inflammatory responses provide measurable pathways connecting Tat exposure with nervous-system injury. Their assessment can show whether the protein is associated with cellular stress, immune activation, or impaired neuronal function in a chosen model. Examining these outcomes together helps clarify how viral effects may extend beyond a single cell type.
Tat-related changes may influence neurons directly while also modifying responses in glial cells and associated immune pathways. This makes the method useful for examining multicellular contributions to neural dysfunction rather than focusing only on isolated neuronal effects. Such interactions can reveal how cellular responses combine to produce broader nervous-system consequences.
Interpretation depends on the Tat preparation, administered dose, delivery route, and experimental model. Differences in any of these variables can change the extent or pattern of observed neural effects, including oxidative stress, inflammation, and neuronal dysfunction. Reporting and controlling these conditions is therefore essential when comparing findings across experiments or evaluating protective strategies.
A study design must specify the Tat preparation, dose, route of delivery, and model in which exposure will occur. These choices determine how the protein reaches the relevant cells or tissues and which nervous-system responses can be examined. Aligning the design with the intended outcome improves interpretation of cellular, tissue, or animal-level findings.
The approach is useful when researchers need to examine how a viral protein may contribute to nervous-system dysfunction. It can support investigation of oxidative stress, inflammatory responses, neuronal effects, and interactions involving glia and immune pathways. Results may help connect cellular mechanisms with HIV-associated neurological disorders and guide evaluation of protective strategies.
Researchers can use Tat exposure as an experimental context for examining whether a proposed protective strategy changes associated neural outcomes. Measurements may focus on oxidative stress, inflammatory responses, signaling changes, or neuronal dysfunction, depending on the model. Because results vary with preparation, dose, route, and model, protection should be interpreted within those defined conditions.